Hollencrest Capital Management’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Hollencrest Capital Management’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-15,000	Closed	-$278K	–	1133
2023 Q3	$278K	Hold	15,000	–	–	0.03%	240
2023 Q2	$166K	Hold	15,000	–	–	0.02%	315
2023 Q1	$201K	Hold	15,000	–	–	0.02%	283
2022 Q4	$186K	Hold	15,000	–	–	0.02%	259
2022 Q3	$209K	Hold	15,000	–	–	0.03%	238
2022 Q2	$207K	Hold	15,000	–	–	0.02%	270
2022 Q1	$244K	Hold	15,000	–	–	0.02%	292
2021 Q4	$244K	Buy	+15,000	New	+$253K	0.02%	305

Hollencrest Capital Management's ICPT Position: Q4 2023 in Review

Hollencrest Capital Management sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2023, closing a stake of 15,000 shares — an estimated $278K sold.

Hollencrest Capital Management first reported a position in ICPT in Q4 2021 and held it in 8 quarters. The position peaked at $278K in Q3 2023. 0 funds tracked by Wall St. Rank hold ICPT as of Q4 2023.

Hollencrest Capital Management reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2023 after selling out during the quarter.
Hollencrest Capital Management sold 15,000 Intercept Pharmaceuticals, Inc. shares in Q4 2023, an estimated $278K.
Hollencrest Capital Management first reported a position in Intercept Pharmaceuticals, Inc. in Q4 2021 and held it in 8 quarters.
Hollencrest Capital Management's Intercept Pharmaceuticals, Inc. position peaked at $278K in Q3 2023.
0 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2023.

Based on Hollencrest Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.